GlassScriptPhysician profile
Brian Scott Stevens
NPI 1245288158
$12,583.65
in general payments reported to CMS, 2019-2025
46 companies · $821 in 2025
The $821 reported for 2025 was more than what 87% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,832 · 2022: $4,959 · 2023: $1,033 · 2024: $2,939 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,405 · Travel and Lodging: $1,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,404.82 |
| Travel and Lodging | $1,388.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,158.22 | 2021-2024 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Tandem Diabetes Care, INC. | $2,357.39 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $957.29 | 2021-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Novo Nordisk INC | $540.70 | 2021-2023 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $467.39 | 2021-2023 | Mounjaro, Humulin, Jardiance |
| Xeris Pharmaceuticals, INC. | $436.98 | 2021-2024 | Gvoke Hypopen |
| Amgen INC. | $379.80 | 2021-2024 | Tepezza, Evenity, Prolia |
| Abbvie INC. | $379.07 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $371.36 | 2021-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $370.26 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $311.45 | 2021-2022 | |
| Antares Pharma, INC. | $262.20 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $241.71 | 2021-2023 | |
| Corcept Therapeutics | $200.97 | 2021 | |
| Abbott Laboratories | $184.76 | 2024-2025 | Freestyle Libre 3 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.